European Archives - Page 42 of 1218 - European Medical Journal

Does Magnesium Aid Glycaemic Control in Type 2 Diabetes?

Understand how magnesium supplementation modestly improves fasting glucose in Type 2 diabetes.

Real-Time Pollen Forecasting App Eases Allergy Symptoms

A recent landmark study is the first randomised, controlled trial to show clinical benefits of an allergy app for SAR sufferers.

Closing Gaps in HAE Management: Understanding What Control Means for Your HAE Patients

This symposium held during the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025 in Glasgow, UK, explores evolving…

Machine Learning Improves Liver Transplant Prediction Accuracy

While other machine learning models like MoRAL-AI and TRAIN-AI have also shown promise, TRIUMPH distinguishes itself through its robust generalisability.

ICML 2025: Bridging Radiotherapy May Reduce CAR-T-Related Toxicity

Bridging radiotherapy (BRT) before CAR-T cell therapy may help reduce severe treatment-related toxicities in patients with B-cell lymphoma…

Malaria Prevention in Pregnancy Threatened by Rising Drug Resistance

A major global study confirms that malaria resistance diminishes IPTp-SP’s antimalarial benefits but not its impact on low birthweight, prompting urgent calls for new preventive strategies.

Study Links IBS to Depression and Sexual Dysfunction

New research shows IBS patients suffer higher depression and worse sexual health compared to healthy individuals, highlighting the condition’s broad impact on wellbeing.

Intense Pulsed Light Outperforms Nicotinamide in Acne Treatment Study

Both treatments resulted in significant improvement in inflammatory acne lesions; however, IPL yielded better overall outcomes.

Music Therapy Offers Relief for Distress in NHS Dementia Wards

Music therapy shows promise for reducing distress in patients with dementia on NHS wards, supporting safer, more compassionate care.

Urodynamics Offers No Added Benefit for Bladder Care

From an economic perspective, urodynamics added £463 in cost and yielded a modest 0.011 additional quality-adjusted life-years.